Physician profile
Jeffrey Simms Larson
NPI 1790269645
$1,598.92
in general payments reported to CMS, 2019-2025
9 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $789 · 2024: $450 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403 · Travel and Lodging: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,402.71 |
| Travel and Lodging | $196.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $289.67 | 2023 | Avance Nerve Graft |
| Inspire Medical Systems, INC. | $263.87 | 2023-2024 | Inspire |
| Aerin Medical INC. | $230.99 | 2023-2025 | |
| Integra Lifesciences Corporation | $160.94 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $155.37 | 2024 | Novosorb Btm |
| Medtronic, INC. | $150.31 | 2023 | Sinuva |
| Abbvie INC. | $127.31 | 2025 | |
| Acclarent, INC | $121.65 | 2023 | Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $98.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.